يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Tanya Fleege"', وقت الاستعلام: 1.03s تنقيح النتائج
  1. 1
    P2.06-021 Efficacy and Safety of ASP8273 versus Erlotinib or Gefitinib as First-Line Treatment in Subjects with EGFRMut+ NSCLC

    المؤلفون: Fei Jie, Dae Ho Lee, Bhardwaj Desai, Ronan J. Kelly, Srinivasu Poondru, Kazuhiko Nakagawa, Tanya Fleege, Debbie Whitcomb, James Chih-Hsin Yang, Anne Keating, Kouji Aoyama, Koichi Uegaki, Leora Horn, Tosei Murase

    المصدر: Journal of Thoracic Oncology. 12:S1083-S1084

    مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, business.industry, First line treatment, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Gefitinib, 030220 oncology & carcinogenesis, Internal medicine, Medicine, Erlotinib, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::39614eb6bbdcd86da6f2704fdac211f3
    https://doi.org/10.1016/j.jtho.2016.11.1514

    View record from ScienceDirect
    أضف إلى المفضلة
  2. 2
    Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study

    المؤلفون: Michael J. Demeure, Tanya Fleege, Srinivasu Poondru, Jihong Chen, Cristina L. Ronchi, Eric Baudin, Francis P. Worden, Harm R. Haak, Martin Fassnacht, Jill Gilbert, Elizabeth Hesseltine, Gary D. Hammer, Alfredo Berruti, A. W. Stephens, Ramona Rorig, David I. Quinn, Massimo Terzolo, Toni K. Choueiri, Matthias Kroiss

    المساهمون: Interne Geneeskunde, RS: CAPHRI School for Public Health and Primary Care, RS: CAPHRI - R1 - Ageing and Long-Term Care

    المصدر: Lancet oncology, 16(4), 426-435. Elsevier Science

    مصطلحات موضوعية: Adult, Male, Linsitinib, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Population, Phases of clinical research, Kaplan-Meier Estimate, Placebo, Disease-Free Survival, Placebos, chemistry.chemical_compound, Double-Blind Method, Internal medicine, Adrenocortical Carcinoma, medicine, Clinical endpoint, Humans, Adrenocortical carcinoma, Neoplasm Metastasis, education, Protein Kinase Inhibitors, Aged, Aged, 80 and over, education.field_of_study, business.industry, Hazard ratio, Imidazoles, Middle Aged, medicine.disease, Surgery, Oncology, chemistry, Tolerability, Pyrazines, Female, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::931e78c05083233aa70e3bda1d1a3f66
    http://hdl.handle.net/2318/1534804

    View record from ScienceDirect Find this article in full text from ProQuest Full Text via ClinicalKey
    أضف إلى المفضلة
  3. 3
    Abstract A47: Clinical profile of ASP8273, a mutant-selective EGFR inhibitor, in subjects with EGFR-mutation positive non-small cell lung cancer: interim results from an ongoing, phase 1, open-label, dose-escalation study

    المؤلفون: Tracey L. Evans, Andrew Krivoshik, Fei Jie, Helena A. Yu, Yan Feng, Leora Horn, Alexander I. Spira, Srinivasu Poondru, Ronan J. Kelly, Anne Keating, Kouji Aoyama, Jared Weiss, Howard West, Debbie Whitcomb, Geoffrey R. Oxnard, Tanya Fleege, Giuseppe Giaccone

    المصدر: Molecular Cancer Therapeutics. 14:A47-A47

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Cancer, medicine.disease, respiratory tract diseases, T790M, Tolerability, Internal medicine, Cohort, medicine, Lung cancer, business, Adverse effect, Progressive disease, EGFR inhibitors

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5c0fca0f19ecc4d1c77b6bb28251109d
    https://doi.org/10.1158/1535-7163.targ-15-a47

    أضف إلى المفضلة
  4. 4
    International randomized, double-blind, placebo-controlled, phase 3 study of linsitinib (OSI-906, L) in patients (pts) with locally advanced or metastatic adrenocortical carcinoma (ACC)

    المؤلفون: Martin Fassnacht, Srinivasu Poondru, Michael J. Demeure, Tanya Fleege, Ramona Rorig, Eric Baudin, David I. Quinn, Gary D. Hammer, Alfredo Berruti

    المصدر: Journal of Clinical Oncology. 32:4507-4507

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Linsitinib, business.industry, Locally advanced, Metastatic Adrenocortical Carcinoma, Cancer, Phases of clinical research, Placebo, medicine.disease, behavioral disciplines and activities, Surgery, Double blind, stomatognathic diseases, chemistry.chemical_compound, nervous system, chemistry, Internal medicine, medicine, In patient, business, human activities, psychological phenomena and processes

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7bcb65ffb6a7be0c00fd843158f6facf
    https://doi.org/10.1200/jco.2014.32.15_suppl.4507

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء